The announcement “Appendix 3Y — Change of Director’s Interest Notice” has been lodged with the Australian Securities Exchange.
Read Appendix 3Y — Change of Director’s Interest Notice.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the